Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-EN Version v4-FR
Language English French
Date Updated 2023-01-28 2023-01-25
Drug Identification Number 02246016 02246016
Brand name THYROGEN THYROGEN
Common or Proper name THYROGEN THYROGEN
Company Name SANOFI GENZYME, A DIVISION OF SANOFI-AVENTIS CANADA INC SANOFI GENZYME, A DIVISION OF SANOFI-AVENTIS CANADA INC
Ingredients THYROTROPIN ALFA THYROTROPIN ALFA
Strength(s) 0.9MG 0.9MG
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAMUSCULAR INTRAMUSCULAR INTRAMUSCULAR INTRAMUSCULAR
Packaging size 2 2
ATC code V04CJ V04CJ
ATC description OTHER DIAGNOSTIC AGENTS OTHER DIAGNOSTIC AGENTS
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date
Actual start date 2022-10-24 2022-10-24
Estimated end date 2023-02-17 2023-02-17
Actual end date 2023-01-27
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Transition between distribution centers. Inventory is available at wholesaler level and orders are being carefully managed to avoid shortage at patient level. Transition between distribution centers. Inventory is available at wholesaler level and orders are being carefully managed to avoid shortage at patient level.
Health Canada comments